Physician profile
Mark Montgomery
NPI 1528012655
$2,906.90
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.88 · 2022: $115 · 2023: $86.13 · 2024: $2,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,613 · Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,612.61 |
| Food and Beverage | $120.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,612.61 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $53.24 | 2022-2023 | Dupixent |
| Genzyme Corporation | $52.58 | 2021-2022 | |
| Optinose US, INC. | $47.24 | 2021-2023 | |
| Glaxosmithkline, LLC. | $46.57 | 2022-2023 | Nucala |
| Merck Sharp & Dohme LLC | $38.35 | 2021-2022 | |
| Acclarent, INC | $34.26 | 2024 | Trudi Nav Cable |
| Amgen INC. | $22.05 | 2023 | Amjevita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.